A genetic screen for mouse mutations with defects in serotonin responsiveness

Molecular Brain Research

Volumn 115, Issue 2, 2003, Pages 162-172

  Weiss, Karin C ^a   Kim, Dennis Y ^a   Pawson, Catherine T ^a   Cordes, Sabine P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Behavior; Mouse; Mutagenesis; Serotonin

Indexed keywords

4 IODO 2,5 DIMETHOXYAMPHETAMINE; ETHYLNITROSOUREA; SEROTONIN; SEROTONIN 2 RECEPTOR; SEROTONIN AGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIORAL SCIENCE; CONTROLLED STUDY; DOSE RESPONSE; FEMALE; GENE SEQUENCE; GENETIC CORRELATION; GENETIC VARIABILITY; GENOMICS; HEAD TWITCH; INDUCED MUTATION; MALE; MOUSE; MOUSE STRAIN; MUTAGENESIS; NEUROMODULATION; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

EID: 0038784461     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(03)00205-5     Document Type: Article

References (28)

1. Anderson K.V. Finding the genes that direct mammalian development: ENU mutagenesis in the mouse. Trends Genet. 16:2000;99-102.
2. Brown S.D. Mouse models of genetic disease: new approaches, new paradigms. J. Inherit. Metab. Dis. 21:1998;532-539.
3. Darmani N.A., Gerdes C.F. Temporal differential adaptation of head-twitch and ear-scratch responses following administration of challenge doses of DOI. Pharmacol. Biochem. Behav. 50:1995;545-550.
4. Darmani N.A., Shaddy J., Gerdes C.F. Differential ontogenesis of three DOI-induced behaviors in mice. Physiol. Behav. 60:1996;1495-1500.
5. Douglas G.R., Gingerich J.D., Soper L.M., Jiao J. Toward an understanding of the use of transgenic mice for the detection of gene mutations in germ cells. Mutat. Res. 388:1997;197-212.
6. Dursun S.M., Handley S.L. Similarities in the pharmacology of spontaneous and DOI-induced head-shakes suggest 5HT2A receptors are active under physiological conditions. Psychopharmacology (Berl). 128:1996;198-205.
7. Fabre V., Beaufour C., Evrard A., Rioux A., Hanoun N., Lesch K.P., Murphy D.L., Lanfumey L., Hamon M., Martres M.P. Altered expression and functions of serotonin 5-HT1A and 5-HT1B receptors in knock-out mice lacking the 5-HT transporter. Eur. J. Neurosci. 12:2000;2299-2310.
8. Gray J.A., Metz A., Goodwin G.M., Green A.R. The effects of the GABA-mimetic drugs, progabide and baclofen, on the biochemistry and function of 5-hydroxytryptamine and noradrenaline. Neuropharmacology. 25:1986;711-716.
9. Heisler L.K., Chu H.M., Brennan T.J., Danao J.A., Bajwa P., Parsons L.H., Tecott L.H. Elevated anxiety and antidepressant-like responses in serotonin 5-HT1A receptor mutant mice. Proc. Natl. Acad. Sci. USA. 95:1998;15049-15054.
10. Hrabe de Angelis M., Balling R. Large scale ENU screens in the mouse: genetics meets genomics. Mutat. Res. 400:1998;25-32.
11. Ikeda A., Zheng Q.Y., Zuberi A.R., Johnson K.R., Naggert J.K., Nishina P.M. Microtubule-associated protein 1A is a modifier of tubby hearing (moth1). Nat. Genet. 30:2002;401-405.
12. Justice M.J., Carpenter D.A., Favor J., Neuhauser-Klaus A., Hrabe de Angelis M., Soewarto D., Moser A., Cordes S., Miller D., Chapman V., Weber J.S., Rinchik E.M., Hunsicker P.R., Russell W.L., Bode V.C. Effects of ENU dosage on mouse strains. Mamm. Genome. 11:2000;484-488.
13. Justice M.J., Noveroske J.K., Weber J.S., Zheng B., Bradley A. Mouse ENU mutagenesis. Hum. Mol. Genet. 8:1999;1955-1963.
14. Mathis C., Neumann P.E., Gershenfeld H., Paul S.M., Crawley J.N. Genetic analysis of anxiety-related behaviors and responses to benzodiazepine-related drugs in AXB and BXA recombinant inbred mouse strains. Behav. Genet. 25:1995;557-568.
15. Mayorga A.J., Dalvi A., Page M.E., Zimov-Levinson S., Hen R., Lucki I. Antidepressant-like behavioral effects in 5-hydroxytryptamine(1A) and 5-hydroxytryptamine(1B) receptor mutant mice. J. Pharmacol. Exp. Ther. 298:2001;1101-1107.
16. Mood A.M. On the assymptotic efficiency of certain non-parametric two-sample tests. Ann. Math. Statist. 25:1954;514-522.
17. Moser P.C., Hitchcock J.M., Lister S., Moran P.M. The pharmacology of latent inhibition as an animal model of schizophrenia. Brain Res. Rev. 33:2000;275-307.
18. Parsons L.H., Kerr T.M., Tecott L.H. 5-HT(1A) receptor mutant mice exhibit enhanced tonic, stress-induced and fluoxetine-induced serotonergic neurotransmission. J. Neurochem. 77:2001;607-617.
19. Rinchik E.M., Carpenter D.A. N-ethyl-N-nitrosourea mutagenesis of a 6- to 11-cM subregion of the Fah-Hbb interval of mouse chromosome 7: completed testing of 4557 gametes and deletion mapping and complementation analysis of 31 mutations. Genetics. 152:1999;373-383.
20. Sallinen J., Haapalinna A., Viitamaa T., Kobilka B.K., Scheinin M. D-amphetamine and L-5-hydroxytryptophan-induced behaviours in mice with genetically-altered expression of the alpha2C-adrenergic receptor subtype. Neuroscience. 86:1998;959-965.
21. Sayah D.M., Khan A.H., Gasperoni T.L., Smith D.J. A genetic screen for novel behavioral mutations in mice. Mol. Psychiatry. 5:2000;369-377.
22. Schmidt C.J., Sorensen S.M., Kehne J.H., Carr A.A., Palfreyman M.G. The role of 5-HT2A receptors in antipsychotic activity. Life Sci. 56:1995;2209-2222.
23. Schreiber R., Brocco M., Audinot V., Gobert A., Veiga S., Millan M.J. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists. J. Pharmacol. Exp. Ther. 273:1995;101-112.
24. Serretti A., Lilli R., Lorenzi C., Lattuada E., Cusin C., Smeraldi E. Serotonin transporter gene (5-HTTLPR) and major psychoses. Mol. Psychiatry. 7:2002;95-99.
25. Singh L., Handley S.L. Behavioural evidence for an interdependence between GABAA receptors and beta 2-adrenoceptors. Eur. J. Pharmacol. 135:1987;419-421.
26. Spielewoy C., Biala G., Roubert C., Hamon M., Betancur C., Giros B. Hypolocomotor effects of acute and daily D-amphetamine in mice lacking the dopamine transporter. Psychopharmacology. 159:2001;2-9.
27. Williams J., McGuffin P., Nothen M., Owen M.J. Meta-analysis of association between the 5-HT2a receptor T102C polymorphism and schizophrenia. EMASS Collaborative Group. European Multicentre Association Study of Schizophrenia. Lancet. 349:1997;1221.
28. Zar J.H. Biostatistical Analysis. 1996;Prentice-Hall, Upper Saddle River, NJ, USA.